Dolor psicógeno

Trullen, J.M. Pérez; Aguilera, José Alfonso Arilla; André, María Luisa Vázquez

doi:10.1016/s1134-5934(08)71128-x

Cited by 2 publications

(4 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It is important here to consider the influence of Franz Nissl (1860-1919) on the formation of A. Alzheimer. 7 12 13 14 Nissl discovered a new staining method, which identifies neurons and is still widely used. 14 They worked together at Municipal Asylum in Frankfurt for 7 years and became friends.…”

Section: The Discovery Of Alois Alzheimermentioning

confidence: 99%

“…When A. Alzheimer got married, Franz Nissl was his best man. 7 13 In addition to having taught how to use his staining method and how to use the camera lucida to draw microscopic images, Nissl has probably taught many other aspects of neuropathology and academic matters, because A. Alzheimer considered Nissl his main mentor. 7 13 In 1903, A. Alzheimer joined Franz Nissl again, who was working under the leadership of Emil Kraepelin at the University Hospital of Heidelberg.…”

Section: The Discovery Of Alois Alzheimermentioning

confidence: 99%

“…7 13 In addition to having taught how to use his staining method and how to use the camera lucida to draw microscopic images, Nissl has probably taught many other aspects of neuropathology and academic matters, because A. Alzheimer considered Nissl his main mentor. 7 13 In 1903, A. Alzheimer joined Franz Nissl again, who was working under the leadership of Emil Kraepelin at the University Hospital of Heidelberg. At the end of the same year, Kraepelin was invited to be the director of the Royal Psychiatric Clinic in Munich and needed someone to create and direct the institution's Neuropathology laboratory.…”

Section: The Discovery Of Alois Alzheimermentioning

confidence: 99%

See 2 more Smart Citations

The past, present and future of Alzheimer's disease – part 1: the past

Nitrini

2023

Arq Neuropsiquiatr

View full text Add to dashboard Cite

Background Alzheimer's disease (AD) was described in 1907, and since then it changed from a relatively rare condition to one of the most prevalent diseases. Objective To describe the evolution of the notions of dementias and AD, and to investigate the reasons for the increase in scientific interest in AD. Methods A historical analysis was carried out on knowledge about dementia, the site of mental activity, the relationships between brain diseases and mental activity, and on the advances in research about AD, since its discovery until the publication of the amyloid cascade hypothesis in 1992. A search was carried out in the National Library of Medicine (PubMed) for scientific articles that included the terms dementia or AD over 50 years, from 1972 to 2021. Results The scientific research on AD increased from 615 papers with the term AD in the first decade (1972-1981), to 100,028 papers in the last decade (2012-2021): an increase of 162.6 times whereas publications with the term dementia increased 28.6 times in the same period. In the 1960s and 1970s, a consensus was reached that AD is responsible for the majority of cases of dementia previously known as senile dementia. In the 1980s, beta-amyloid peptide was identified in the core of the senile plaque, hyperphosphorylated tau protein was found in neurofibrillary tangles, and a mutation was discovered in a hereditary form of AD. Conclusion The expansion of the concept of AD to include senile dementia, and the discoveries that occurred in the 1980s greatly expanded research in AD.

show abstract

Section: The Discovery Of Alois Alzheimermentioning

confidence: 99%

Section: The Discovery Of Alois Alzheimermentioning

confidence: 99%

Section: The Discovery Of Alois Alzheimermentioning

confidence: 99%

See 1 more Smart Citation

The past, present and future of Alzheimer's disease – part 1: the past

Nitrini

2023

Arq Neuropsiquiatr

View full text Add to dashboard Cite

show abstract

“…Los cuadros de simulación de los trastornos somatomorfos tienen un beneficio secundario evidente, los trastornos facticios no tienen beneficio secundario [7]. Los trastornos facticios se distinguen de los trastornos somatoformes en que estos últimos no tienen intenciones de engañar al clínico [8].…”

Section: Introductionunclassified

Aproximación médico-legal al paciente con trastorno facticio

Hernández-Aragón¹,

Paz-González²

2019

Colomb. forense

View full text Add to dashboard Cite

Introducción: los trastornos facticios son patologías poco comunes y por ello subdiagnosticadas. Es por esto que el personal de salud tiene poca exposición y experiencia en cómo abordar y tratar a este tipo de pacientes. El interés de este artículo es el de presentar un caso y correlacionar la manera como se debe de hacer el manejo de estos pacientes para evitar que el médico entre en problemas legales.Métodos y materiales: el artículo es un reporte de caso que se acompaña de revisión de la literatura. Se encontraron 14 artículos que tenían datos relevantes para la presentación de este tema. Además, se utilizó el Código Penal del Estado de Nuevo León como base en cuanto a la parte legal de este documento.Historia del caso: este caso hace referencia al caso de una mujer de 49 años que presentó un cuadro de debilidad progresiva que no respondía a causa orgánica y que además se agravaba con la presencia de familiares.Resultados y discusión: los trastornos facticios son caracterizados por la invención, producción o falsificación de síntomas tanto físicos como psicológicos que simulan una enfermedad física o mental. El perfil de estos pacientes hace que sea difícil su abordaje. El tratante debe de ser cauteloso con las implicaciones legales que puede conllevar.Conclusiones: los trastornos facticios son poco diagnosticados. La formación de un equipo multidisciplinario es lo más aceptado y a lo que se debe de aspirar.

show abstract

Dolor psicógeno

Cited by 2 publications

References 18 publications

The past, present and future of Alzheimer's disease – part 1: the past

The past, present and future of Alzheimer's disease – part 1: the past

Aproximación médico-legal al paciente con trastorno facticio

Contact Info

Product

Resources

About